112 related articles for article (PubMed ID: 19915714)
1. Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400 microg in Healthy Japanese Volunteers.
Darwish M; Tempero K; Jiang JG; Simonson PG
Arch Drug Inf; 2008 Sep; 1(2):50-55. PubMed ID: 19915714
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
3. Dose Proportionality of Fentanyl Buccal Tablet in Healthy Japanese Volunteers.
Darwish M; Tempero K; Jiang JG; Thompson J; Simonson PG
Arch Drug Inf; 2008 Sep; 1(2):43-49. PubMed ID: 19915713
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 microg in healthy subjects.
Darwish M; Kirby M; Jiang JG; Tracewell W; Robertson P
Clin Drug Investig; 2008; 28(1):1-7. PubMed ID: 18081355
[TBL] [Abstract][Full Text] [Related]
5. Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study.
Darwish M; Kirby M; Robertson P; Tracewell W; Xie F
Clin Drug Investig; 2010; 30(6):365-73. PubMed ID: 20441245
[TBL] [Abstract][Full Text] [Related]
6. Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers.
Darwish M; Tempero K; Jiang JG; Simonson PG
Arch Drug Inf; 2008 Sep; 1(2):56-62. PubMed ID: 19915709
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
[TBL] [Abstract][Full Text] [Related]
8. Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Drug Investig; 2007; 27(9):605-11. PubMed ID: 17705569
[TBL] [Abstract][Full Text] [Related]
9. Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet.
Darwish M; Kirby M; Jiang JG
Expert Opin Pharmacother; 2007 Sep; 8(13):2011-6. PubMed ID: 17714055
[TBL] [Abstract][Full Text] [Related]
10. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
Clin Pharmacokinet; 2006; 45(8):843-50. PubMed ID: 16884321
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of fentanyl buccal tablet: a pooled analysis and review.
Darwish M; Xie F
Pain Pract; 2012 Apr; 12(4):307-14. PubMed ID: 21831253
[TBL] [Abstract][Full Text] [Related]
12. Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study.
Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 22128878
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat.
Ashburn MA; Ogden LL; Zhang J; Love G; Basta SV
J Pain; 2003 Aug; 4(6):291-7. PubMed ID: 14622685
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl buccal tablet.
Messina J; Darwish M; Fine PG
Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
[TBL] [Abstract][Full Text] [Related]
17. Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers.
Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
J Clin Pharmacol; 2007 Jan; 47(1):56-63. PubMed ID: 17192502
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers.
Vasisht N; Gever LN; Tagarro I; Finn AL
J Clin Pharmacol; 2010 Jul; 50(7):785-91. PubMed ID: 20150521
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P
Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
[TBL] [Abstract][Full Text] [Related]
20. Effect of dosing interval on pharmacokinetics of fentanyl pectin nasal spray from a crossover study.
Chen C; Bujanover S; Gupta A
J Opioid Manag; 2015; 11(2):139-46. PubMed ID: 25901479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
